SINGAPORE, Sept. 25, 2024 /PRNewswire/ — Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, is excited to announce the remarkable 170th anniversary of Roots, a noteworthy milestone in not only the blower and compressor sector but across all industries. Originally established in the woolen mills of Connersville, Indiana, USA, Roots […]
Category Archives: Pr Newswire
Media Kit: DFC at UNGA 2024 NEW YORK, Sept. 25, 2024 /PRNewswire/ — Today, participating G7 development finance institutions (DFIs), MedAccess, the European Investment Bank (EIB), and the International Finance Corporation (IFC) announced the signing of a memorandum of understanding (MoU) for the Surge Financing Initiative for Medical Countermeasures (MCMs). These DFIs are working closely with global […]
LONDON, Sept. 25, 2024 /PRNewswire/ — Over the past week, eagle-eyed golf fans and residents in major cities across the world have spotted a mysterious shield pattern popping up in a variety of locations: Tokyo city centre, the sidewalks of Seoul, a natural area outside of Montreal, graffiti art in Cape Town and a beach […]
TORONTO, Sept. 25, 2024 /PRNewswire/ — Maropost, the commerce software suite built for fast-growing retail and ecommerce brands, today announced the appointment of two industry veterans to its executive team: David Charron as Chief Financial Officer (CFO) and Jim Koepke as Chief Revenue Officer (CRO). Ross Andrew Paquette, Chairman and CEO of Maropost, emphasized the […]
A pioneering study, presented today at the EADV Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity. AMSTERDAM, Sept. 25, 2024 /PRNewswire/ — This is the first study to explore the use of semaglutide for HS, marking a critical milestone in the […]
24
Sep
Sep
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) — Company to host conference call today at 8.30 a.m. ET Continued progress within core activities in RNA delivery, supported by move into new R&D facilities Publications by independent research groups provide fresh evidence of effective mRNA delivery to extrahepatic targets Major territory expansion with two distribution […]
Pr Newswire
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”
24
Sep
Sep
TRxADE Health, Inc. today announced that it changed its name and ticker symbol to “Scienture Holdings, Inc.” and “SCNX”, respectively, and that the business will continue as a Nasdaq-listed company. TAMPA, FL, Sept. 24, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (the “Company”) (Nasdaq: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of the […]
24
Sep
Sep
TEMPE, Ariz., Sept. 24, 2024 (GLOBE NEWSWIRE) — Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced today that it received a 2024 AZBio™ Fast Lane Award from the Arizona Bioindustry Association (AZBio). Each year a select group of Arizona-based life science companies are recognized for the progress they are making […]
Pr Newswire
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
24
Sep
Sep
DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 25% patient enrollment at Emergency Departments (“ED”) for its U.S. Burn Pivotal Study and […]
Pr Newswire
FDA Accepts Arcutis’ Supplemental New Drug Application for ZORYVE® (roflumilast) Foam for the Treatment of Scalp and Body Psoriasis in Adults and Adolescents Ages 12 and Over
24
Sep
Sep
U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of May 22, 2025 Almost half of the 9 million individuals in the United States with plaque psoriasis experience involvement of the scalp Supplemental New Drug Application (sNDA) supported by positive efficacy and safety data from Phase […]